Contact Us

Bio-Etc Pte Ltd
60, Paya Lebar Road,
#11-06 Paya Lebar Square,
Singapore 409051

 

Tel: +65 9025 9897
Email: info@bio-etc.com

Social Media

[ADIPOGEN]: New and Unique SARS-CoV-2 Variants Neutralizing Antibodies Detection Assays and Proteins

[ADIPOGEN]: New and Unique SARS-CoV-2 Variants Neutralizing Antibodies Detection Assays and Proteins

Since the COVID-19 pandemic began a range of SARS-CoV-2 variants have emerged across the world. Most attention has been drawn on fast-spreading variants, recently identified B.1.1.7 (UK), B.1.351 (South Africa) and P.1 (Brazil). Scientists suspect that the variants’ particular patterns of mutations have the potential to affect their transmissibility, virulence and/or ability to evade parts of the immune system. The latter could make people with vaccine-induced or natural immunity to SARS-CoV-2 vulnerable to becoming reinfected with novel variants and these possible effects remain under investigation.

After the release of its highly specific SARS-CoV-2 Neutralizing Antibodies Detection Kit (Prod. No. AG-48B-0002) last year,  AdipoGen Life Sciences has now developed and produced new and unique Neutralizing Antibodies Detection Kits for the UK, Brazil and South African Variants of SARS-CoV-2. All assays are unique and are available from stock.

 

NEW & UNIQUE
SARS-CoV-2 Neutralizing Antibodies Detection Kits

SARS-CoV-2 Neutralizing Antibodies Detection Kit (B.1.1.7 Variant, UK) AG-48B-0003
SARS-CoV-2 Neutralizing Antibodies Detection Kit (P.1 Variant, BR) AG-48B-0004
SARS-CoV-2 Neutralizing Antibodies Detection Kit (B.1.351 Variant, SA) AG-48B-0005
SARS-CoV-2 Neutralizing Antibodies Detection Kit
(B.1.617 Variant, IND) IN DEVELOPMENT
Please Inquire
STANDARD FOR INITIAL SARS-CoV-2 STRAIN
SARS-CoV-2 Neutralizing Antibodies Detection Kit
AG-48B-0002

LIT: Comparison of two commercial surrogate ELISAs to detect a neutralizing antibody response to SARS-CoV-2: K. Mueller, et al.; J. Virol. Methods 292, 114122 (2021)

 

SARS-CoV-2 Variant Proteins for Assay Development!

SARS-CoV-2 Spike Protein S1 (RBD) (rec.) (His) (B.1.1.7 Variant, UK) AG-40B-0205
SARS-CoV-2 Spike Protein S1 (RBD) (rec.) (His) (B.1.351 Variant, SA) AG-40B-0206
SARS-CoV-2 Spike Protein S1 (RBD) (rec.) (His) (P.1 Variant, BR) AG-40B-0207
SARS-CoV-2 Spike Protein S1 (RBD):Fc (human) (rec.) (B.1.1.7 Variant, UK) AG-40B-0202
SARS-CoV-2 Spike Protein S1 (RBD):Fc (human) (rec.) (B.1.351 Variant, SA) AG-40B-0203
SARS-CoV-2 Spike Protein S1 (RBD):Fc (human) (rec.) (P.1 Variant, BR) AG-40B-0204